Skip to main content
Erschienen in: Netherlands Heart Journal 12/2012

01.12.2012 | Original Article

Cardiac operative risk evaluation: The EuroSCORE II, does it make a real difference?

verfasst von: L. Noyez, P. C. Kievit, H. A. van Swieten, M.-J. de Boer

Erschienen in: Netherlands Heart Journal | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The EuroSCORE, worldwide used as a model for prediction of mortality after cardiac surgery, has recently been renewed. Since October 2011, the EuroSCORE II calculator is available at the EuroSCORE website and recommended for clinical use. The intention of this paper is to compare the use of the initial EuroSCORE and EuroSCORE II as a risk evaluation tool.

Methods

100 consecutive patients who underwent combined mitral valve and coronary bypass surgery (MVR + CABG) and 100 consecutive patients undergoing combined aortic valve surgery and coronary bypass surgery (AVR + CABG) at the Radboud University Nijmegen Medical Center before 10 October 2011 were included. For both groups the initial EuroSCORE and the EuroSCORE II model were used for risk calculation and based on the calculated risks, cumulative sum charts (CUSUM) were constructed to evaluate the impact on performance monitoring.

Results

For the MVR + CABG group the calculated risk using the initial logistic EuroSCORE was 9.95 ± 8.47 (1.51–45.37) versus 5.08 ± 4.03 (0.67–19.76) for the EuroSCORE II. For the AVR + CABG group 9.50 ± 8.6 (1.51–69.5) versus 4.77 ± 6.6 (0.96–64.24), respectively. For both groups the calculated risk by the EuroSCORE II was statistically lower compared with the initial EuroSCORE (p < 0.001). This lower expected risk has influence on performance monitoring, using risk-adjusted CUSUM analysis.

Conclusion

The EuroSCORE II, based on a recently updated database, reduces the overestimation of the calculated risk by the initial EuroSCORE. This difference is statistically significant and the EuroSCORE II may also reflect better current surgical performance.
Literatur
1.
Zurück zum Zitat Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–45.PubMedCrossRef Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–45.PubMedCrossRef
2.
Zurück zum Zitat Nashef SAM, Roques F, Michel P, et al. European system for cardiac preoperative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.PubMedCrossRef Nashef SAM, Roques F, Michel P, et al. European system for cardiac preoperative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.PubMedCrossRef
3.
Zurück zum Zitat Parolari A, Pesce LL, Trezzi M, et al. EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg. 2010;89(3):787–93.PubMedCrossRef Parolari A, Pesce LL, Trezzi M, et al. EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg. 2010;89(3):787–93.PubMedCrossRef
4.
Zurück zum Zitat Basraon J, Chandrashekhar YS, John R, et al. Comparison of risk scores to estimate periopertive mortality in aortic valve replacement surgery. Ann Thorac Surg. 2011;92(2):535–40.PubMedCrossRef Basraon J, Chandrashekhar YS, John R, et al. Comparison of risk scores to estimate periopertive mortality in aortic valve replacement surgery. Ann Thorac Surg. 2011;92(2):535–40.PubMedCrossRef
5.
Zurück zum Zitat Noyez L. Control charts, CUSUM techniques and funnel plots. A review of methods for monitoring performance in healthcare. Interact Cardiovasc Thorac Surg. 2009;9:494–9.PubMedCrossRef Noyez L. Control charts, CUSUM techniques and funnel plots. A review of methods for monitoring performance in healthcare. Interact Cardiovasc Thorac Surg. 2009;9:494–9.PubMedCrossRef
6.
Zurück zum Zitat Vahanian A, Alfieri O, Al-Attor N, et al. Transcather valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463–70.PubMedCrossRef Vahanian A, Alfieri O, Al-Attor N, et al. Transcather valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463–70.PubMedCrossRef
7.
Zurück zum Zitat Wouters CW, Noyez L. Is no news good news? Organized follow-up, an absolute necessity for the evaluation of myocardial revascularization. Eur J Cardiothorac Surg. 2004;26:667–70.PubMedCrossRef Wouters CW, Noyez L. Is no news good news? Organized follow-up, an absolute necessity for the evaluation of myocardial revascularization. Eur J Cardiothorac Surg. 2004;26:667–70.PubMedCrossRef
8.
Zurück zum Zitat Steyerberg EW, Eijkemans MJ, Harrel FE, et al. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059–79.PubMedCrossRef Steyerberg EW, Eijkemans MJ, Harrel FE, et al. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059–79.PubMedCrossRef
9.
Zurück zum Zitat Noyez L, Kievit PC, Verkroost MWA, et al. Evaluation of quality in adult cardiac surgery: let us speak the same language. Neth Heart J. 2010;18:365–9.PubMedCrossRef Noyez L, Kievit PC, Verkroost MWA, et al. Evaluation of quality in adult cardiac surgery: let us speak the same language. Neth Heart J. 2010;18:365–9.PubMedCrossRef
10.
Zurück zum Zitat Baan J, Yong ZY, Koch KT, et al. Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement. Neth Heart J. 2010;18:16–24. Baan J, Yong ZY, Koch KT, et al. Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement. Neth Heart J. 2010;18:16–24.
Metadaten
Titel
Cardiac operative risk evaluation: The EuroSCORE II, does it make a real difference?
verfasst von
L. Noyez
P. C. Kievit
H. A. van Swieten
M.-J. de Boer
Publikationsdatum
01.12.2012
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 12/2012
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-012-0327-1

Weitere Artikel der Ausgabe 12/2012

Netherlands Heart Journal 12/2012 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.